Machine Learning to Allocate Palliative Care Consultations During Cancer Treatment
Jiang Chen He(Ontario Institute for Cancer Research), Robert C. Grant(Princess Margaret Cancer Centre), Steven Gallinger(Ontario Institute for Cancer Research), Ning Liu, Ferhana Khan, Breffni Hannon(University of Toronto), Nathan Taback(Ontario Institute for Cancer Research), Marzyeh Ghassemi(Vector Institute), Monika K. Krzyzanowska(Sunnybrook Health Science Centre), Gordon Taylor Moffat(University Health Network), Sho Podolsky, Kelvin Chan(Occupational Cancer Research Centre)
Cited by 21
Related Papers
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
|Journal of Clinical Oncology|2007|3.9k
TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods
|BMJ|2024|2.8k
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
|New England Journal of Medicine|2003|2.1k